ALASTIN Skincare® Announces Issuance Of U.S. Patent Based On Revolutionary TriHex Technology®

Novel Technology Leads the Way in a New Category of Procedure Enhancement Products for the Aesthetic Market.

CARLSBAD, CA — October 30, 2018 — ALASTIN Skincare®, Inc. - a specialty
aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, announces that the United States Patent and Trademark Office has issued U.S. Patent No. 10,086,035 entitled "Compositions and Methods for Invasive and Non-invasive Procedural Skin Care". The patent covers topical compositions for promoting skin repair based on Alastin's platform TriHex Technology®.

Products with Alastin’s TriHex Technology® have created a new category within the aesthetic market to address a previously unmet need for topical products that provide complementary benefits for patients undergoing rejuvenating procedures. These products are designed to help patients prepare the skin prior to a procedure, speed healing and enhance outcomes post-procedure. Alastin's Procedure Enhancement Line of products supports the body’s natural healing processes related to generation of new collagen and elastin after a procedure. This novel TriHex Technology® is also incorporated into Alastin’s Restore & Renew daily skin care line to improve skin health, helping the skin repair the wear and tear from normal aging and exposure to the sun and air pollution.

"According to the 2017 report from the American Society of Plastic Surgeons, there were over 15 million minimally invasive aesthetic procedures in the US, and this trend is growing rapidly," commented Diane S. Goostree, CEO of ALASTIN Skincare. "We are pleased to provide patented products based on TriHex Technology® to our physician partners and their patients to enhance these procedures, and for daily skin care."

Visit alastin.com to find a physician retailer near you.